Information  X 
Enter a valid email address

Company Name matching 'AroCell AB'

Date
Time Source
Company
Announcement
18 Sep 2019 4:10 pm GNW     AroCell AB Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment
11 Sep 2019 1:00 pm GNW     AroCell AB AroCell expands with a Regulatory Affairs Director
21 Aug 2019 7:00 am GNW     AroCell AB AroCell AB (publ) Interim Report January 1st to June 30th 2019
06 Aug 2019 7:15 am GNW     AroCell AB AroCell signs a new distributor agreement in the USA and Canada
01 Aug 2019 4:15 pm GNW     AroCell AB AroCell enters a collaboration with Dana Farber Cancer Institute
16 May 2019 1:30 pm GNW     AroCell AB Report from the Annual General Meeting of AroCell AB (publ) 2019
  7:00 am GNW     AroCell AB AroCell AB (publ) Interim Report 1st January to 31st March 2019
02 May 2019 7:00 am GNW     AroCell AB AroCell expands its distribution network and signs distribution agreement with Inveniolife
17 Apr 2019 7:00 am GNW     AroCell AB Notice of Annual General Meeting of Arocell ab (publ)
  7:00 am GNW     AroCell AB AroCell establish a Scientific Advisory Board
15 Apr 2019 7:00 am GNW     AroCell AB AroCell and Corgenix establish the measurement of Thymidine Kinase 1 using AroCell TK 210 ELISA in a CLIA-lab in the USA
12 Apr 2019 10:30 am GNW     AroCell AB AroCell´s 2018 Annual Report published
20 Mar 2019 10:00 am GNW     AroCell AB New AroCell patent granted by the EPO  
  9:27 am GNW     AroCell AB CORRECTED VERSION of March 20, 2019 Press Release: New scientific publication from AroCell on TK 210 ELISA in prostate cancer
  8:30 am GNW     AroCell AB New scientific publication from AroCell on TK 210 ELISA in prostate cancer
28 Feb 2019 9:30 am GNW     AroCell AB Abstract from AroCell accepted for poster presentation during AACR 2019
25 Feb 2019 7:30 am GNW     AroCell AB New study results with AroCell TK 210 ELISA in prostate cancer has been accepted for publication
21 Feb 2019 7:30 am GNW     AroCell AB AroCell AB (publ) Year-End Report 2018
01 Feb 2019 12:32 pm GNW     AroCell AB AroCell launches new website
25 Jan 2019 2:30 pm GNW     AroCell AB AroCell is a member of SwedenBIO
15 Jan 2019 7:00 am GNW     AroCell AB AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA
20 Dec 2018 7:00 am GNW     AroCell AB AroCell signs distribution agreement with Eurobio Scientific in France
11 Dec 2018 7:30 am GNW     AroCell AB A new scientific publication from AroCell confirming the value of AroCell TK 210 ELISA as a tool in drug discovery and development
27 Nov 2018 2:00 pm GNW     AroCell AB AroCell presents results from the U-CAN TK1 lymphoma study and from a comparison study between TK 210™ ELISA and other assays
23 Oct 2018 2:45 pm GNW     AroCell AB AroCell AB announces the appointment of a new CEO
17 Oct 2018 7:30 am GNW     AroCell AB Patent granted in the US
09 Oct 2018 7:40 am GNW     AroCell AB A second abstract accepted at ISOBM in Hamburg demonstrating enhanced diagnostic value when using AroCell’s proprietary sample preparation method
18 Sep 2018 10:30 am GNW     AroCell AB A new study comparing TK 210™ ELISA from AroCell with other activity-based assays for the measurement of TK1 in serum shows high correlation between methods when samples from subjects with hematological malignancies are compared. The study
29 Aug 2018 2:15 pm GNW     AroCell AB Patent reinforces AroCell’s opportunities in the US market
24 Aug 2018 12:50 pm GNW     AroCell AB New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t